Komarkcorp Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Komarkcorp Berhad şirketinin toplam hissedar öz sermayesi MYR98.8M ve toplam borcu MYR9.3M olup, bu da borç-öz sermaye oranını 9.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR125.0M ve MYR26.1M dir.

Anahtar bilgiler

9.4%

Borç/özkaynak oranı

RM 9.32m

Borç

Faiz karşılama oranı	n/a
Nakit	RM 24.57m
Eşitlik	RM 98.84m
Toplam yükümlülükler	RM 26.13m
Toplam varlıklar	RM 124.97m

Son finansal sağlık güncellemeleri

Recent updates

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Jun 09

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Oct 29

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Apr 08

If You Had Bought Komarkcorp Berhad (KLSE:KOMARK) Shares Three Years Ago You'd Have Earned 371% Returns

Dec 24

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: KOMARK 'nin kısa vadeli varlıkları ( MYR40.4M ) kısa vadeli yükümlülüklerini ( MYR16.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: KOMARK şirketinin kısa vadeli varlıkları ( MYR40.4M ) uzun vadeli yükümlülüklerini ( MYR9.5M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: KOMARK şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: KOMARK 'nin borç/öz sermaye oranı son 5 yılda 18.8% seviyesinden 9.4% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: KOMARK şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: KOMARK un, serbest nakit akışı her yıl % 17.4 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Komarkcorp Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Recent updates

Full year 2024 earnings released: RM0.15 loss per share (vs RM0.031 loss in FY 2023)

Komarkcorp Berhad, Annual General Meeting, Nov 27, 2024

Komarkcorp Berhad, Annual General Meeting, Nov 14, 2024

Komarkcorp Berhad Announces Cessation of Office of Tengku Ezuan Ismara Bin Tengku Nun Ahmad as Independent and Non Executive Chairman of Remuneration Committee

New minor risk - Share price stability

New minor risk - Share price stability

Full year 2024 earnings released: RM3.81 loss per share (vs RM0.03 loss in FY 2023)

Third quarter 2024 earnings released: RM0.007 loss per share (vs RM0.003 profit in 3Q 2023)

New major risk - Financial position

Second quarter 2024 earnings released: RM0.002 loss per share (vs RM0.003 profit in 2Q 2023)

New major risk - Market cap size

Full year 2023 earnings released: RM0.006 loss per share (vs RM0.015 loss in FY 2022)

Komarkcorp Berhad, Annual General Meeting, Sep 21, 2023

New major risk - Shareholder dilution

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

Komarkcorp Berhad Appoints Azizah Binti Sulaiman as Independent and Non Executive Member of Remuneration Committee

Full year 2023 earnings released: RM0.008 loss per share (vs RM0.019 loss in FY 2022)

Komarkcorp Berhad Announces Resignation of Encik Ihsan Bin Ismail as Independent and Non Executive Member of Remuneration Committee

High number of new and inexperienced directors

Full year 2022 earnings released: RM0.019 loss per share (vs RM0.034 loss in FY 2021)

Komarkcorp Berhad, Annual General Meeting, Sep 21, 2022

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.034 loss in FY 2021)

High number of new and inexperienced directors

Does Komarkcorp Berhad (KLSE:KOMARK) Have A Healthy Balance Sheet?

High number of new and inexperienced directors

First quarter 2022 earnings released: RM0.008 loss per share (vs RM0.004 loss in 1Q 2021)

Full year 2021 earnings released: RM0.031 loss per share (vs RM0.027 loss in FY 2020)

Komarkcorp Berhad has completed a Follow-on Equity Offering in the amount of MYR 12.932371 million.

Company Secretary has left the company

Independent & Non-Executive Director has left the company

Is Komarkcorp Berhad (KLSE:KOMARK) Using Debt Sensibly?

Third quarter 2021 earnings released: RM0.011 loss per share (vs RM0.01 loss in 3Q 2020)

Komarkcorp Berhad's Subsidiary Komark Mask (M) Sdn Bhd and Robayu Corporation SP. ZO. O Enter into Supply and Purchase Agreement

New 90-day high: RM0.71

Komark Mask (M) Sdn Bhd Receives FDA and CE Certification

New 90-day low: RM0.41

New 90-day low: RM0.41

New 90-day low: RM0.81

New 90-day low: RM0.90

Komarkcorp Berhad Announces the Appointment of Tan Tong Lang as Company Secretary

Komarkcorp Berhad Announces Resignation of Tai Yit Chan as Joint Secretary, Effective from January 01, 2021

Second quarter 2021 earnings released: RM0.011 loss per share

If You Had Bought Komarkcorp Berhad (KLSE:KOMARK) Shares Three Years Ago You'd Have Earned 371% Returns

Komarkcorp Berhad Announces That Its Subsidiary, Komark Mask Signs Distributorship Agreement with LKL Advance Metaltech Sdn Bhd

Komarkcorp Berhad Announces Resignation of Mr. Chong Jiun Shyang as Chief Financial Officer to Pursue Other Interests

New 90-day high: RM1.28

Komarkcorp Berhad Announces Resignation of Roy Ho Yew Kee as Executive Chairman of Remuneration Committee

Komarkcorp Berhad Appoints Ym Tengku Ezuan Ismara Bin Tengku Nun Ahmad as Independent and Non Executive Chairman of Remuneration Committee

Komarkcorp Berhad Announces Redesignation of Koh Chie Jooi from Chief Operating Officer to Group Chief Executive Officer

First quarter earnings released

New 90-day high - RM1.10

Full year earnings released - RM0.048 loss per share

New 90-day high - RM0.89

New 90-day high - RM0.63

An undisclosed buyer acquired 19.9% stake in Komarkcorp Berhad (KLSE:KOMARK) from KOH HONG MUAN @ KOH GAK SIONG

New 90-day high - RM0.49

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin